CAS RN: 18557-22-7

4,9-Dibromonaphtho[2,3-c][1,2,5]thiadiazole

Product Availability

Choose a grade to view its available package options.

5 package records5 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250324 100mg / 500mg / 1g Confirm by inquiry Shanghai, Shandong Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260630 100mg In stock Shanghai Inquiry
Batchno.20260404 1g In stock Shanghai, Tianjin Inquiry
Batchno.20250702 250mg In stock Shanghai, Shenzhen Inquiry
Batchno.20251115 50mg In stock Shanghai Inquiry
  • Product code: SSC-085899
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.25g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 18557-22-7
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.25g ≥95% 0 Out of Stock Shanghai Inquiry

18557-22-7 / 4,9-dibromobenzo[f][2,1,3]benzothiadiazole

Standard CAS: 18557-22-7 Multi CAS: No

Basic Information

CAS
18557-22-7
Multi CAS
No
Molecular Formula
C10H4Br2N2S
Molecular Weight
344.030000
Exact Mass
343.844150
SMILES
C1=CC2=C(C3=NSN=C3C(=C2C=C1)Br)Br
InChI
InChI=1S/C10H4Br2N2S/c11-7-5-3-1-2-4-6(5)8(12)10-9(7)13-15-14-10/h1-4H
InChIKey
XGTQHVQKGZSPIK-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
15
Aromatic heavy atom count
13
H-bond acceptors
3
Molar refractivity
70.32
TPSA
25.78

LogP / Solubility

WLOGP
4.37
MLOGP
3.86
XLogP3
4.4
Consensus LogP
4.21
Log S (ESOL)
-5.37
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.54
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.52
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.72

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5

Get In Touch

Contact Us